PPARG and metabolic dysfunction-associated steatohepatitis: Activated PPARγ inhibited miR-21-5p transcriptional activity by targeting the miR-21-5p promoter region, thereby inhibiting lipid droplet accumulation, oxidative stress, and hepatic inflammation in a mouse model of non-alcoholic steatohepatitis (NASH) [51].